Amanat Kaur

Thermo Fisher Scientific
Operational Excellence Engineer
Amanat is a Professional Engineer with design, process and automation experience in cGMP manufacturing environments, including cell gene therapy, vaccine, API, and fill-finish manufacturing facilities. Currently, she is a Operational Excellence Engineer with Thermo Fisher Scientific. Her experience includes continuous improvement projects for processes, equipment, utilities, and automation (IT/OT).

She is proficient at leading projects, meeting project timelines, and working with cross-functional teams. With extensive management experience, she is adept at guiding teams, fostering improvement, and strategic decision-making. She graduated with a master’s degree (thesis-based) in Bioresource Engineering from McGill University.

Amanat is passionate and driven to break barriers, foster growth, and make a positive impact. She spends a lot of her time volunteering for different non-profit organizations. Her active volunteer roles include serving on the Executive Board for ISPE Canada Affiliate and Biotech CoP advisory board member for ISPE Global.

She is also an Engineer-In-Residence with Engineers of Tomorrow where she helps promote STEM amongst the younger generation. Amanat supports these organizations to keep advocating for excellence while inspiring others to chase their aspirations and create meaningful change.

Related Articles

Unveiling the Excitement: Your EMERGING LEADERS Guide to #ISPEAM23
iSpeak Blog
Unveiling the Excitement: Your EMERGING LEADERS Guide to #ISPEAM23

The countdown has begun, and the anticipation is evident as we gear up for the highly anticipated 2023 ISPE Annual Meeting & Expo. As we look back at the successful conferences over the past years, this event promises to be nothing short of extraordinary, especially for students and Emerging Leaders.

The Next Horizon for Therapy Innovations
iSpeak Blog
The Next Horizon for Therapy Innovations

The industry is continuously evolving to meet new requirements. Many of these requirements include adhering to global regulatory harmonization, improving supply chain robustness, minimizing drug shortages, reducing the complexity of managing product life cycles, and reducing the environmental impact of pharmaceutical processes. At the